オオタ マコト
  太田 眞   スポーツ・健康科学部 健康科学科   教授
■ 標題
  Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study):a randomized,open-label,blind end point morbility study
■ 概要
  Seibu Mochizuki, Ikuo Taniguchi, Katsunori Ikewaki, Makoto Ohta, et al Valsartan will improve morbidity and mortality when added to conventional therapies in Japanese patients with hypertension and cardiovascular disease.For the first time, the clinical benefits of valsartan added to the benefits from blood pressure control, are extended to an Asian population.The JIKEI Heart Study results are highly relevant to clinical practice.We have to consider not only aggressive blood pressure control but also which blood pressure drug is the best choice to prevent outcomes
  Lancet 2007;369:1431-39      2007


Copyright(C) 2011 Daito Bunka University, All rights reserved.